Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk. - Wikidata - awgldk - TriplyDB

Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk.

Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk.

http://www.wikidata.org/entity/Q36706640

about

Are cancer-related decision aids appropriate for socially disadvantaged patients? A systematic review of US randomized controlled trials.Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting.Self-guided management of exome and whole-genome sequencing results: changing the results return model.Awareness of cancer susceptibility genetic testing: the 2000, 2005, and 2010 National Health Interview Surveys.Familial breast cancer: Genetic counseling over time, including patients´ expectations and initiators considering the Angelina Jolie effect.Awareness, knowledge, perceptions, and attitudes towards genetic testing for cancer risk among ethnic minority groups: a systematic review.Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative.Rates of BRCA1/2 mutation testing among young survivors of breast cancer Can mHealth Improve Risk Assessment in Underserved Populations? Acceptability of a Breast Health Questionnaire App in Ethnically Diverse, Older, Low-Income Women.Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling.Ethical concerns related to developing pharmacogenomic treatment strategies for addiction.BRCA genetic counseling among at-risk Latinas in New York City: new beliefs shape new generation.Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer.Genetic counseling for hereditary breast and ovarian cancer among Puerto Rican women living in the United States.From observation to intervention: development of a psychoeducational intervention to increase uptake of BRCA genetic counseling among high-risk breast cancer survivors Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.Barriers to the use of personalized medicine in breast cancer.Do Breast Cancer Patients Tested in the Oncology Care Setting Share BRCA Mutation Results with Family Members and Health Care Providers?Addressing health disparities in Hispanic breast cancer: accurate and inexpensive sequencing of BRCA1 and BRCA2.The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective A high frequency of BRCA mutations in young black women with breast cancer residing in Florida.Attitudes of patients with cancer about personalized medicine and somatic genetic testing.Impact of a primary care based intervention on breast cancer knowledge, risk perception and concern: A randomized, controlled trial.Are race-specific ERCC1 haplotypes in melanoma cases versus controls related to the predictive and prognostic value of ERCC1 N118N?Balancing personalized medicine and personalized care Bridging the Communication Divide: A Role for Health Psychology in the Genomic Era.Variation in receipt of radiation therapy after breast-conserving surgery: assessing the impact of physicians and geographic regions.Migrant breast cancer patients and their participation in genetic counseling: results from a registry-based study.Patient Perceptions of Telephone vs. In-Person BRCA1/BRCA2 Genetic Counseling.Age-specific incidence of breast cancer subtypes: understanding the black-white crossover.Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals Cancer Survivorship Care: An Opportunity to Revisit Cancer Genetics.Symposium on advances in endometrial cancer epidemiology and biology.Participation of low-income women in genetic cancer risk assessment and BRCA 1/2 testing: the experience of a safety-net institution.Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer Utilization of epidermal growth factor receptor (EGFR) testing in the United States: a case study of T3 translational research.Using Genetic Technologies To Reduce, Rather Than Widen, Health Disparities.Cognitive and psychological impact of BRCA genetic counseling in before and after definitive surgery breast cancer patients.Risks of nutrigenomics and nutrigenetics? What the scientists say.The Contribution of Health Care and Other Interventions to Black-White Disparities in Life Expectancy, 1980-2007.

P2860

Q27307763-D6EEA2AC-A3DE-44BA-837C-01BB9D7369BE Q33564013-97907E87-9406-41F8-90A9-59863B69F26C Q33566296-7AE82C27-B4B9-41F4-812A-E87E2BB71E6C Q33703141-52AC3C55-1F66-4876-A45D-ECF9DDA7B2D8 Q33727903-97263AED-2D19-4A9C-972B-B1BE853FBF55 Q33730576-6B4FF0DB-B941-417D-B279-D6357370DB1C Q33900845-09175935-35C7-4BE3-8FF6-553541DE7E67 Q33923031-7A69D903-4739-4794-967A-9037850F0210 Q35105485-81C6E799-20A8-49BF-AB0C-7C91A118212D Q35192381-0F91ED3F-AF84-4D3B-ACB6-8777ABD70870 Q35286480-5B716C8E-CDD2-4C2A-ABE1-0C0D96736AEA Q35446401-5C5ECF98-688C-4538-BAFE-135D13D66B52 Q35854671-9B0EA508-4D9C-403F-A4DD-CC73D4C34AD7 Q35934793-DF0C182F-C55E-449A-9DD9-7E4B51CD4007 Q35939791-803510AE-45D5-48FF-9026-0A7E1750E194 Q35998356-C5342057-8F58-4A0D-AE8F-BB44F7E26EC7 Q36095254-BF8645D9-FCBA-4CFA-B101-FA47A0D46C1A Q36110947-85823714-2302-4FFD-A529-FE7EFCAEBC79 Q36252996-033168F1-7DD3-4B62-9FED-228860DAEE79 Q36322846-8C82060C-3D2F-4020-A538-FEEFC512B8FA Q36338690-149D5A11-AB48-474A-B953-6CDAAB397259 Q36406057-5BA6DC51-7D64-4A5E-9A13-4478339B6CE0 Q36422319-5750F5A0-FD23-4A79-BDE2-B6090A1CF88F Q36545959-286A5E8F-0A4B-4D0C-8669-F86308A14F3D Q36644366-B4F0D71C-27E6-4A7B-B793-EBF9CD67331B Q36678417-DA80811B-2D30-4244-93EC-0238F85A7A70 Q36681065-451ACF94-8C4E-442D-AA3C-162071E3C216 Q36717818-DE74FA46-AE36-4F25-8476-93637D944B09 Q36792125-8B69ECA8-B624-43A4-B360-5F12AD466493 Q36806636-0A7A0B8D-FC99-4C20-AFEB-B89218D7BA9D Q36904144-90BDD8BC-43EA-46CD-B4DA-30947ADB85EF Q36914464-28AE5DA6-BDA0-4A51-830E-113F4E776E54 Q37011786-AD403646-2E7F-4B14-B472-2FBB3F8E8320 Q37124106-2CEB4C3C-A1FB-44FF-95B3-9D0907E00EAF Q37234825-C97FAB33-54CA-44C3-8B51-0231F0AE3129 Q37238134-B8790689-1775-40BA-A8A4-629A0538B931 Q37401308-C41D0C6B-A097-4367-9A4B-29311D141A50 Q37426280-3892D064-5C5A-49DE-A674-A31A57A37C06 Q37496610-DB263D58-BD98-4B84-9818-8DF5C75098C1 Q37586842-66B6067F-F29D-48EA-B76E-8445A5411A4A

P2860

Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk.

http://www.wikidata.org/entity/Q36706640

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Underutilization of BRCA1/2 te ...... ic women particularly at risk.

@ast

Underutilization of BRCA1/2 te ...... ic women particularly at risk.

@en

type

label

Underutilization of BRCA1/2 te ...... ic women particularly at risk.

@ast

Underutilization of BRCA1/2 te ...... ic women particularly at risk.

@en

prefLabel

Underutilization of BRCA1/2 te ...... ic women particularly at risk.

@ast

Underutilization of BRCA1/2 te ...... ic women particularly at risk.

@en

P1433

Q36706640-6353BE24-17B9-4FF9-90BE-687EA5683410

P1476

Q36706640-DDE6BE17-C1A1-4F37-BF90-C83A9B1214D0

P2093

Q36706640-0E46072E-7ECE-49F8-9A02-065134B0ECB1

Q36706640-19D12873-E385-44A5-A8DA-CE28EE44BF0A

Q36706640-1F91D880-C529-4137-86B7-C80267F031F2

Q36706640-20F35677-62B0-4376-A9BF-B0F90F81CAA0

Q36706640-6280D90C-80C0-4B90-B5D7-C5A4264D1E35

Q36706640-9C6115BB-52C6-4D15-A10B-E63AB1850F48

Q36706640-CC98F3CF-9C08-4708-94FF-6C51FEC0BABD

P2860

Q36706640-05070397-238B-4AE3-8ABC-C4BD63865F0E

Q36706640-0953D09D-E5E8-4465-8470-6CD068E75AED

Q36706640-2F03D026-9042-41EF-9F7E-C71F8EFAB427

Q36706640-3345FF6F-E08D-48E1-B5EE-D624E9D30605

Q36706640-34184859-1223-4E5B-9A1C-19B980DC0226

Q36706640-344AC9E9-DD8E-47BF-8017-B566D0977F48

Q36706640-3EDFAF48-CA39-47EA-9D66-BAB452B6772E

Q36706640-4015CEFB-B404-4A51-B4FA-8BCCEB48A300

Q36706640-4C2647BF-941D-4292-9D34-863ACDE5C507

Q36706640-64276EE1-19C7-40D8-89FD-3045BACFE83E

P2888

Q36706640-C323A243-7DA8-4ADD-B36E-A422753A6C6A

P304

Q36706640-12C71E8F-2173-4563-894A-AFF4DD45B371

P31

Q36706640-23520665-268E-47D3-9CAB-27949F66A844

P356

Q36706640-7A5D52C1-3858-43E5-B38B-196A1752601D

P407

Q36706640-9F3F0FF0-0554-44C3-83BD-16420ACF124B

P433

Q36706640-ADEA5381-2030-44C9-8C9B-354595F62061

P478

Q36706640-695682E7-1F7B-4EEB-8080-F86E36E80DB4

P577

Q36706640-55D03B52-3FAC-4B89-839C-689125D208EF

P6179

Q36706640-21B34706-04D8-49EC-A616-25792239B9DC

P698

Q36706640-0FAEA111-089C-4856-9A96-5C79AC202461

P932

Q36706640-9CAF6412-E59A-48A3-990B-2C01AAEB8901

P356

GIM.0B013E3182091BA4

P1433

Genetics in Medicine

P1476

Underutilization of BRCA1/2 te ...... ic women particularly at risk.

@en

P2093

Alexandra E Shields

http://www.w3.org/2001/XMLSchema#string

Catherine B Comstock

http://www.w3.org/2001/XMLSchema#string

Douglas E Levy

http://www.w3.org/2001/XMLSchema#string

Judy E Garber

http://www.w3.org/2001/XMLSchema#string

Sapna Syngal

http://www.w3.org/2001/XMLSchema#string

Stacey D Byfield

http://www.w3.org/2001/XMLSchema#string

William H Crown

http://www.w3.org/2001/XMLSchema#string

P2860

Concentration and quality of hospitals that care for elderly black patients

Why don't physicians follow clinical practice guidelines? A framework for improvement

How do women decide? Accepting or declining BRCA1/2 testing in a nationwide clinical sample in the United States.

Primary care physicians who treat blacks and whites.

Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.

American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

The association between race and attitudes about predictive genetic testing.

Cancer disparities by race/ethnicity and socioeconomic status.

Triangulating differential nonresponse by race in a telephone survey

Prevalence of BRCA mutations and founder effect in high-risk Hispanic families.

P2888

gim.0b013e3182091ba4

P304

349-355

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/GIM.0B013E3182091BA4

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1034208612

http://www.w3.org/2001/XMLSchema#string

P698

21358336

http://www.w3.org/2001/XMLSchema#string

P932

3604880

http://www.w3.org/2001/XMLSchema#string